BioCryst Advancing Potential Treatment for Rare and Severely Debilitating Fibrodysplasia Ossifica… Post author:Sam Post published:January 4, 2018 Post category:BioPharma FOP is a very rare disease that affects approximately 1 in 2 million people worldwide. Source: BioSpace You Might Also Like Horizon Pharma Pays $145 Million For And Its Rare Eye Disease Drug May 7, 2017 W. L. Gore & Associates Release: GORE VIATORR TIPS Endoprosthesis With Controlled Expansion May Reduce Portal Hypertension Readmissions In Ongoing Study July 31, 2017 ProQR Therapeutics B.V. Appoints As Chief Development Strategy Officer March 26, 2017
W. L. Gore & Associates Release: GORE VIATORR TIPS Endoprosthesis With Controlled Expansion May Reduce Portal Hypertension Readmissions In Ongoing Study July 31, 2017
